Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1622996/000164033421001236/acbm_10q.htm
Document And Entity Information - shares | 3 Months Ended | |
---|---|---|
Mar. 31, 2021 | May 24, 2021 | |
Document And Entity Information [Abstract] | ||
Entity Registrant Name | ACRO BIOMEDICAL CO., LTD. | |
Entity Central Index Key | 0001622996 | |
Entity Current Reporting Status | Yes | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Non-accelerated Filer | |
Entity Common Stock, Shares Outstanding | 47,760,000 | |
Document Type | 10-Q | |
Document Period End Date | Mar. 31, 2021 | |
Amendment Flag | false | |
Document Fiscal Year Focus | 2021 | |
Document Fiscal Period Focus | Q1 | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Interactive Data Current | Yes |
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1622996/000164033421001236/acbm_10q.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Acro Biomedical Co., Ltd..
Acro Biomedical Co., Ltd.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:
Material Contracts, Statements, Certifications & more
Acro Biomedical Co., Ltd. provided additional information to their SEC Filing as exhibits
Ticker: ACBM
CIK: 1622996
Form Type: 10-Q Quarterly Report
Accession Number: 0001640334-21-001236
Submitted to the SEC: Mon May 24 2021 3:22:07 PM EST
Accepted by the SEC: Mon May 24 2021
Period: Wednesday, March 31, 2021
Industry: Amusement And Recreation Services